Treatment Response and Tolerability of Pegylated Interferon-alpha Plus Ribavirin Combination Therapy in Elderly Patients (>= 65 years) With Chronic Hepatitis C in Korea

Sang Wook Kim; In Hee Kim; Seung-Ok Lee

Treatment Response and Tolerability of Pegylated Interferon-alpha Plus Ribavirin Combination Therapy in Elderly Patients (>= 65 years) With Chronic Hepatitis C in Korea

Department of Medicine

Research output: Contribution to journal › Journal article › peer-review

Original language	Korean
Journal	Hepatitis Monthly
State	Published - 2012.07.30

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Cite this

@article{a73683f7e8b44d63bf7fc3eb1cc961c2,

title = "Treatment Response and Tolerability of Pegylated Interferon-alpha Plus Ribavirin Combination Therapy in Elderly Patients (>= 65 years) With Chronic Hepatitis C in Korea",

author = "Kim, \{Sang Wook\} and Kim, \{In Hee\} and Seung-Ok Lee",

year = "2012",

month = jul,

day = "30",

language = "Korean",

journal = "Hepatitis Monthly",

issn = "1735-143X",

}